SMC treatment could restore the ALT, AST, ALP, TP, albumin, creatinine, and uric acid levels toward the normal levels as measured on the 7th and 14th day after infection, revealing the protective effect of SMC, particularly the high dose, which showed a higher protection than diclazuril. The gene discussed is ALB; the disease is infection.